Medidoor – Medicines
This study introduces Medidoor -Medicines, a healthcare-based startup initiative designed to make medicines more affordable and accessible, particularly for the middle-income population in India. The venture operates on a free home delivery model, offering both standard and generic medicines at discounted rates while maintaining profitability through a well-structured margin distribution among sales representatives, delivery personnel, and the company itself. Customer acquisition focuses on direct outreach— engaging individuals in public spaces like petrol stations, hospitals, schools, and marketplaces—to build a base of regular patients who require monthly medications for chronic illnesses such as diabetes, thyroid, and blood pressure. The startup also plans to expand by collaborating with diagnostic labs for low-cost medical tests, establishing its inventory center in local areas, and eventually offering free doctor consultations to customers who purchase medicines through the platform. This research outlines the potential of Medidoor - Medicines to become a cost-effective and community-focused healthcare solution, highlighting its role in addressing medical accessibility challenges while maintaining a sustainable and scalable business framework.
Authors
- V. K. Redasani
- Yash V. Gaikwad Yash V. Gaikwad
- Charushila M. Kharat Charushila M. Kharat
- Ms. Vaishnavi S. Shedge Ms. Vaishnavi S. Shedge
- Avinash M. Bhagwa Dr. Avinash M. Bhagwa
Publication Details
- Journal
- International Journal of Pharmaceutical Research and Applications
- Published
- 2025-03-01
- DOI
- https://doi.org/10.35629/4494-1003282286
- Primary Topic
- Health and Medical Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00